← Back

US Federal Register - DEA Telehealth Rules · United States · 16 Mar 2020 · Rule change

DEA Registration and Reregistration Fees for Controlled Substance and List I Chemical Registrants

The Drug Enforcement Administration proposes adjusting the fee schedule for registration and reregistration fees necessary to recover the costs of its Diversion Control Program relating to the registration and control of the manufacture, distribution, dispensing, importation and exportation of controlled substances and list I chemicals as mandated by the Controlled Substances Act.